SCHEMBL30973442

SCHEMBL30973442

Oc1csc2cc(Cl)nnc12

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30434181 0.76 CYP2A6 (0.40) TDP1
SCHEMBL26973210 0.65 KMT2A (0.30) —
SCHEMBL10321593 0.61 — —
SCHEMBL29549774 0.61 — —
SCHEMBL26973212 0.60 TDP1 (0.30) TDP1
Ammonia Solution, Strong SCHEMBL26650853 0.60 TDP1 (0.30) TDP1
Ammonia Solution, Strong SCHEMBL31373461 0.60 TDP1 (0.30) TDP1
SCHEMBL17703504 0.58 — —
SCHEMBL11308803 0.57 HSD17B10 (0.50) TDP1
SCHEMBL27014225 0.57 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642784-A1 HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 PTC Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
WO-2024145623-A1 HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 PTC THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback